Short answers to the questions researchers ask most about retatrutide. For depth, follow the links to our full articles.
What is retatrutide?
An investigational triple-receptor agonist (GLP-1 + GIP + glucagon). See the full explainer.
How is it different from semaglutide and tirzepatide?
It targets three receptors instead of one or two. See the comparison.
Is it FDA-approved?
No. It is investigational and offered for research only.
What purity should I look for?
99%+, confirmed by a third-party COA. See why COAs matter and our COA library.
How is it stored?
Lyophilized vials refrigerated; reconstituted solution refrigerated and used within a limited window. See storage & stability.
Where can I get research-grade retatrutide?
RDAmd offers USA-made, COA-verified 10mg, 20mg, and 30mg research vials.
Take our 60-second quiz for a personalized recommendation and unlock 35% off your first order of USA-made, COA-verified GLP.
For research and educational use only. The information here is not medical advice and RDAmd products are not intended to diagnose, treat, cure, or prevent any disease or for human consumption. Retatrutide is an investigational compound and is not approved by the FDA. Always consult a qualified professional.
